Einhorn LH et al., 1977-09: Single-arm series of 50 patients with disseminated testicular cancer treated with cisplatin, vinblastine and bleomycin. 74% complete and 26% partial remissions, with 85% overall disease-free status after resection of residual disease.
This chemotherapy regimen produced 74% complete and 26% partial remissions. Furthermore, five patients with partial remission became disease-free after surgical removal of residual disease, producing an overall 85% disease-free status.
p.293 (Abstract)
Einhorn LH et al., 1977-09: Single-arm series of 50 patients with disseminated testicular cancer treated with cisplatin, vinblastine and bleomycin. 74% complete and 26% partial remissions, with 85% overall disease-free status after resection of residual disease. No funding or disclosure statement in the MEDLINE record. Drugs: cisplatin, vinblastine, bleomycin; no manufacturer named. Comparator: none – a single-arm series, so 85% is not a randomised comparison and there is no concurrent control arm. This is the paper normally credited with opening the cisplatin cure era. Study type: uncontrolled series.
